on MEDIAN TECHNOLOGIES (EPA:ALMDT)
Eyonis Inc Wins Prestigious "Rising Star" Award for Lung Cancer Screening Innovation
November 17, 2026 – Eyonis Inc, a Median Technologies company, has been awarded the "Rising Star" title at the 2026 Digital Health Hub Foundation Digital Health & AI Awards. The accolade acknowledges the firm's groundbreaking eyonis® LCS solution, which offers AI-powered lung cancer screening.
Recognized for its ability to improve early lung cancer diagnosis, eyonis® LCS is the first and only software to receive both FDA clearance and CE marking. This innovation combines nodule detection and diagnostic evaluation, significantly reducing false positives and negatives compared to traditional methods.
Eyonis Inc was selected from over 1,300 companies worldwide for the Cancer, Screening & Early Detection category. The award was presented at the global HLTH 2026 conference in Las Vegas. The company’s software demonstrates a noteworthy 93.3% sensitivity and 92.4% specificity.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all MEDIAN TECHNOLOGIES news